XMT-1660: A Phase 1b trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancersErika Hamilton,Alexander Spira,Sylvia Adams,Nour Abuhadra,Antonio Giordano,Ritesh Parajuli,Hyo Han,Amy Weise,Aubri Marchesani, Kate Josephs,Arvind Chaudhry,Kevin KalinskyGYNECOLOGIC ONCOLOGY(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要